查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1225297

流感診斷市場：2023-2028 年全球行業趨勢、份額、規模、增長、機遇和預測

Influenza Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 145 Pages | 商品交期: 2-3個工作天內

價格

到 2022 年，全球流感診斷市場規模將達到 8.934 億美元。 展望未來，IMARC Group 預計到 2028 年將達到 14.617 億美元，2023 年至 2028 年的增長率 (CAGR) 為 6.55%。

流感是一種病毒感染，主要影響人類的鼻子、喉嚨和肺等呼吸系統。 流感診斷包括許多免疫測定測試，有助於檢測呼吸道標本中是否存在甲型和乙型流感核蛋白抗原。 常用的診斷測試包括快速抗原測試、逆轉錄-聚合□鏈反應 (RT-PCR)、免疫熒光分析、血清學測試和快速分子分析。 醫療機構可以通過查看其敏感性和特異性來評估這些測試的準確性，這是決定這些測試準確性水平的關鍵因素。

流感診斷市場趨勢

  • 哮喘、慢性阻塞性肺病 (COPD)、支氣管擴張和囊性纖維化等幾種增加流感風險的慢性病患病率上升，在很大程度上推動了全球流感診斷市場的發展。 此外，易患呼吸道感染的老年人口不斷增加也推動了市場增長。 此外，先進診斷免疫測定形式的日益普及以及流感診斷中越來越多地使用小型化儀器也對全球市場產生了積極影響。 此外，引入 CLIA 豁免 POC 分子流感測試以及將消費者偏好從集中式實驗室轉變為分散式即時檢驗也推動了市場增長。 此外，快速流感診斷測試 (RIDT) 的日益普及也成為重要的增長動力，這些測試易於使用並可在大約 15 分鐘內得出結果。 此外，世衛組織加強流感監測、監測和數據利用的各種舉措也推動了市場的增長。 因此，許多政府機構都在積極採取預防措施，以降低流感的風險。 例如，美國疾病預防控制中心和東南亞地區 (SEAR) 合作開展非研究性雙邊流感支持，以應對禽流感、季節性流感和大流行性流感。 在接下來的幾年裡，人工智能 (AI) 在流感診斷中的日益整合，以最大限度地縮短樣本處理時間並促進無差錯結果，預計將推動全球流感診斷市場的發展。

主要市場細分

  • IMARC Group 分析了全球流感診斷市場報告每個子部分的主要趨勢，以及 2023 年至 2028 年在全球、區域和國家層面的預測。 該報告根據產品、測試類型、流感類型和最終用戶對市場進行分類。

按產品細分

  • 檢測試劑盒和試劑
  • 檢驗設備
  • 其他

按測試類型細分

  • 分子生物學診斷測試
  • 聚合□鏈反應
  • 等位核酸擴增法
  • 其他分子生物學測試
  • 常規診斷試劑
  • 流感快速診斷測試
  • 病毒培養測試
  • 直接熒光抗體法
  • 血清學檢測

按類型劃分的流感分類

  • 甲型流感
  • 乙型流感
  • 丙型流感

最終用戶細分

  • 醫院
  • 診斷機構
  • 其他

按地區劃分

  • 北美
  • 美國
  • 加拿大
  • 亞太地區
  • 中國
  • 日本
  • 印度
  • 韓國
  • 澳大利亞
  • 印度尼西亞
  • 其他
  • 歐洲
  • 德國
  • 法國
  • 英國
  • 意大利
  • 西班牙
  • 俄羅斯
  • 其他
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 其他
  • 中東和非洲

內容

第1章前言

第 2 章研究方法和範圍

  • 調查的目的
  • 利益相關者
  • 數據來源
    • 主要信息
    • 次要信息
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章執行摘要

第4章介紹

  • 概覽
  • 主要行業趨勢

第 5 章全球流感診斷市場

  • 市場概覽
  • 市場結果
  • COVID-19 的影響
  • 市場預測

第 6 章按產品劃分的市場細分

  • 檢測試劑盒和試劑
    • 市場趨勢
    • 市場預測
  • 樂器
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第 7 章按測試類型劃分的市場細分

  • 分子生物學診斷劑
    • 市場趨勢
    • 主要細分市場
      • 聚合□鏈反應
      • 等溫核酸擴增法
      • 其他分子生物學測試
    • 市場預測
  • 常規診斷試劑
    • 市場趨勢
    • 主要細分市場
      • 流感快速診斷試劑
      • 病毒培養測試
      • 直接熒光抗體法
      • 血清學檢測
    • 市場預測

第 8 章流感類型市場細分

  • 甲型流感
    • 市場趨勢
    • 市場預測
  • 乙型流感
    • 市場趨勢
    • 市場預測
  • 丙型流感
    • 市場趨勢
    • 市場預測

第 9 章最終用戶的市場細分

  • 醫院
    • 市場趨勢
    • 市場預測
  • 診斷實驗室
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第 10 章區域市場細分

  • 北美
    • 美國
      • 市場趨勢
      • 市場預測
    • 加拿大
      • 市場趨勢
      • 市場展望
  • 亞太地區
    • 中國
      • 市場趨勢
      • 市場展望
    • 日本
      • 市場趨勢
      • 市場預測
    • 印度
      • 市場趨勢
      • 市場展望
    • 韓國市場
      • 市場趨勢
      • 市場展望
    • 澳大利亞
      • 市場趨勢
      • 市場展望
    • 印度尼西亞
      • 市場趨勢
      • 市場展望
    • 其他
      • 市場趨勢
      • 市場預測
  • 歐洲
    • 德國
      • 市場趨勢
      • 市場展望
    • 法國
      • 市場趨勢
      • 市場預測
    • 英國
      • 市場趨勢
      • 市場預測
    • 意大利
      • 市場趨勢
      • 市場展望
    • 西班牙
      • 市場趨勢
      • 市場展望
    • 俄羅斯
      • 市場趨勢
      • 市場展望
    • 其他
      • 市場趨勢
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場趨勢
      • 市場展望
    • 墨西哥
      • 市場趨勢
      • 市場展望
    • 其他
      • 市場趨勢
      • 市場預測
  • 中東和非洲
    • 市場趨勢
    • 按國家/地區劃分的市場細分
    • 市場展望

第 11 章 SWOT 分析

  • 概覽
  • 強度
  • 弱點
  • 機會
  • 威脅

第12章價值鏈分析

第13章搬運工五力分析

  • 概覽
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第14章價格分析

第15章競爭格局

  • 市場結構
  • 主要公司
  • 主要公司簡介
    • Abbott Laboratories
    • Becton Dickinson and Company
    • Coris Bioconcept
    • Danaher Corporation
    • DiaSorin S.p.A.
    • F. Hoffmann-La Roche Ltd（Roche Holding AG）
    • Hologic Inc.
    • Meridian Bioscience Inc.
    • Qiagen N.V
    • Quidel Corporation
    • Sekisui Diagnostics LLC（Sekisui Medical Co. Ltd.）
    • Siemens Healthineers AG（Siemens AG）
Product Code: SR1423A138_Report

The global influenza diagnostics market size reached US$ 893.4 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,461.7 Million by 2028, exhibiting a growth rate (CAGR) of 6.55% during 2023-2028.

Influenza, or flu, refers to a viral infection that mainly affects the human respiratory system, including the nose, throat, and lungs. Influenza diagnostics includes numerous immunoassay tests that aid in detecting the presence of influenza A and B viral nucleoprotein antigens in respiratory specimens. Some of the commonly available diagnostic tests include rapid antigen testing, reverse transcription polymerase chain reaction (RT-PCR), immunofluorescence assays, serology, and rapid molecular assays. Healthcare facilities can assess the precision of these tests by looking at their sensitivity and specificity, which are crucial factors that determine their accuracy levels.

Influenza Diagnostics Market Trends:

  • The elevating prevalence of several chronic diseases, such as asthma, chronic obstructive pulmonary disease (COPD), bronchiectasis, cystic fibrosis, etc., that increase the risk of influenza, is primarily driving the global influenza diagnostics market. Besides this, the expanding geriatric population, who are more prone to respiratory tract infections, is also catalyzing the market growth. Additionally, the rising availability of advanced diagnostic immunoassay formats along with the growing usage of miniaturized devices in influenza diagnostics is positively influencing the global market. Moreover, the introduction of CLIA-waived POC molecular influenza tests and the shifting consumer preferences from centralized laboratories to decentralized point-of-care testing are also augmenting the market growth. In addition to this, the emerging popularity of rapid influenza diagnostic test (RIDT) that are convenient to use and provide results in approximately fifteen minutes is acting as a significant growth-inducing factor. Furthermore, various initiatives by WHO to strengthen influenza surveillance, monitoring, and data utilization, are also stimulating the market growth. In line with this, numerous government bodies are becoming more actively involved in taking preventative steps to reduce the risk of influenza. For instance, the U.S. CDC and the South-East Asian Region (SEAR) have collaborated to support non-researched bilateral influenza as a response to avian, seasonal, and pandemic influenza. In the coming years, the growing integration of artificial intelligence (AI) in influenza diagnostics to minimize the timelines for sample processing and facilitate error-free results is expected to drive the global influenza diagnostics market.

Key Market Segmentation:

  • IMARC Group provides an analysis of the key trends in each sub-segment of the global influenza diagnostics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, test type, type of flu and end user.

Breakup by Product:

  • Test Kit and Reagents
  • Instruments
  • Others

Breakup by Test Type:

  • Molecular Diagnostic Tests
  • Polymerase Chain Reaction
  • Isothermal Nucleic Acid Amplification Tests
  • Other Molecular Tests
  • Traditional Diagnostic Tests
  • Rapid Influenza Diagnostic Tests
  • Viral Culture Tests
  • Direct Fluorescent Antibody Test
  • Serological Tests

Breakup by Type of Flu:

  • Type A Flu
  • Type B Flu
  • Type C Flu

Breakup by End User:

  • Hospitals
  • Diagnostic Laboratories
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

  • The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Becton Dickinson and Company, Coris Bioconcept, Danaher Corporation, DiaSorin S.p.A., F. Hoffmann-La Roche Ltd (Roche Holding AG), Hologic Inc., Meridian Bioscience Inc., Qiagen N.V, Quidel Corporation, Sekisui Diagnostics LLC (Sekisui Medical Co. Ltd.) and Siemens Healthineers AG (Siemens AG).
  • Key Questions Answered in This Report
  • 1. What was the size of the global influenza diagnostics market in 2022?
  • 2. What is the expected growth rate of the global influenza diagnostics market during 2023-2028?
  • 3. What are the key factors driving the global influenza diagnostics market?
  • 4. What has been the impact of COVID-19 on the global influenza diagnostics market?
  • 5. What is the breakup of the global influenza diagnostics market based on the product?
  • 6. What is the breakup of the global influenza diagnostics market based on the test type?
  • 7. What is the breakup of the global influenza diagnostics market based on type of flu?
  • 8. What is the breakup of the global influenza diagnostics market based on the end user?
  • 9. What are the key regions in the global influenza diagnostics market?
  • 10. Who are the key players/companies in the global influenza diagnostics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Influenza Diagnostics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Test Kit and Reagents
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Instruments
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Others
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Test Type

  • 7.1 Molecular Diagnostic Tests
    • 7.1.1 Market Trends
    • 7.1.2 Key Segments
      • 7.1.2.1 Polymerase Chain Reaction
      • 7.1.2.2 Isothermal Nucleic Acid Amplification Tests
      • 7.1.2.3 Other Molecular Tests
    • 7.1.3 Market Forecast
  • 7.2 Traditional Diagnostic Tests
    • 7.2.1 Market Trends
    • 7.2.2 Key Segments
      • 7.2.2.1 Rapid Influenza Diagnostic Tests
      • 7.2.2.2 Viral Culture Tests
      • 7.2.2.3 Direct Fluorescent Antibody Test
      • 7.2.2.4 Serological Tests
    • 7.2.3 Market Forecast

8 Market Breakup by Type of Flu

  • 8.1 Type A Flu
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Type B Flu
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Type C Flu
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Diagnostic Laboratories
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Others
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Abbott Laboratories
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Becton Dickinson and Company
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Coris Bioconcept
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 Danaher Corporation
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 DiaSorin S.p.A.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 F. Hoffmann-La Roche Ltd (Roche Holding AG)
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 SWOT Analysis
    • 15.3.7 Hologic Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Meridian Bioscience Inc.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Qiagen N.V
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Quidel Corporation
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Sekisui Diagnostics LLC (Sekisui Medical Co. Ltd.)
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
    • 15.3.12 Siemens Healthineers AG (Siemens AG)
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Influenza Diagnostics Market: Major Drivers and Challenges
  • Figure 2: Global: Influenza Diagnostics Market: Sales Value (in Million US$), 2017-2022
  • Figure 3: Global: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 4: Global: Influenza Diagnostics Market: Breakup by Product (in %), 2022
  • Figure 5: Global: Influenza Diagnostics Market: Breakup by Test Type (in %), 2022
  • Figure 6: Global: Influenza Diagnostics Market: Breakup by Type of Flu (in %), 2022
  • Figure 7: Global: Influenza Diagnostics Market: Breakup by End User (in %), 2022
  • Figure 8: Global: Influenza Diagnostics Market: Breakup by Region (in %), 2022
  • Figure 9: Global: Influenza Diagnostics (Test Kit and Reagents) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Influenza Diagnostics (Test Kit and Reagents) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Influenza Diagnostics (Instruments) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Influenza Diagnostics (Instruments) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Influenza Diagnostics (Other Products) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Influenza Diagnostics (Other Products) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Influenza Diagnostics (Molecular Diagnostic Tests) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Influenza Diagnostics (Molecular Diagnostic Tests) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Influenza Diagnostics (Traditional Diagnostic Tests) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Influenza Diagnostics (Traditional Diagnostic Tests) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Influenza Diagnostics (Type A Flu) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Influenza Diagnostics (Type A Flu) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Influenza Diagnostics (Type B Flu) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Influenza Diagnostics (Type B Flu) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Influenza Diagnostics (Type C Flu) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Influenza Diagnostics (Type C Flu) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: Influenza Diagnostics (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: Influenza Diagnostics (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Global: Influenza Diagnostics (Diagnostic Laboratories) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Global: Influenza Diagnostics (Diagnostic Laboratories) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Global: Influenza Diagnostics (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Global: Influenza Diagnostics (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: North America: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: North America: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: United States: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: United States: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: Canada: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: Canada: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: Asia-Pacific: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: Asia-Pacific: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: China: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: China: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: Japan: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: Japan: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: India: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: India: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: South Korea: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: South Korea: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: Australia: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: Australia: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: Indonesia: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: Indonesia: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: Others: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: Others: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: Europe: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: Europe: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: Germany: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: Germany: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: France: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: France: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: United Kingdom: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: United Kingdom: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Italy: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Italy: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: Spain: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: Spain: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: Russia: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: Russia: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: Others: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: Others: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: Latin America: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: Latin America: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Brazil: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: Brazil: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Mexico: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: Mexico: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Others: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 76: Others: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Middle East and Africa: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 78: Middle East and Africa: Influenza Diagnostics Market: Breakup by Country (in %), 2022
  • Figure 79: Middle East and Africa: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 80: Global: Influenza Diagnostics Industry: SWOT Analysis
  • Figure 81: Global: Influenza Diagnostics Industry: Value Chain Analysis
  • Figure 82: Global: Influenza Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Influenza Diagnostics Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Influenza Diagnostics Market Forecast: Breakup by Product (in Million US$), 2023-2028
  • Table 3: Global: Influenza Diagnostics Market Forecast: Breakup by Test Type (in Million US$), 2023-2028
  • Table 4: Global: Influenza Diagnostics Market Forecast: Breakup by Type of Flu (in Million US$), 2023-2028
  • Table 5: Global: Influenza Diagnostics Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 6: Global: Influenza Diagnostics Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 7: Global: Influenza Diagnostics Market: Competitive Structure
  • Table 8: Global: Influenza Diagnostics Market: Key Players